Objective The primary aim of this paper is to accelerate the number of randomized
experimental studies of the reliability and validity in-home tele-neuropsychological testing …

Introduction Mild cognitive impairment (MCI) is a prodromal stage to dementia, affecting up
to 20% of the aging population worldwide. Patients with MCI have an annual conversion rate …

Introduction This increasing body of literature indicates that menopause hormonal
replacement therapy (MHT) may substantially mitigate the risk of developing late‐life …

Mild neurocognitive impairment (MNI) refers to a transitory stage between normal cognitive
decline due to progressive aging and an early stage of dementia. It usually includes both …

Background Artificial intelligence models tailored to diagnose cognitive impairment have
shown excellent results. However, it is unclear whether large linguistic models can rival …

Objective: Debate continues regarding the use of self-versus informant-report to diagnose
mild cognitive impairment (MCI) with studies reporting patients both overestimating and …

Whether individuals with mild cognitive impairment (MCI) and a history of major depressive
disorder (MDD) are at a higher risk for cognitive decline than those with MCI alone is still not …

Dementia is a highly prevalent condition with devastating clinical and socioeconomic
sequela. It is expected to triple in prevalence by 2050. No treatment is currently known to be …

Major depressive disorder (MDD) is associated with an increased risk of developing
dementia. The present study aimed to better understand this risk by comparing resting state …

Background Almost half of older patients with major depressive disorder (MDD) present with
cognitive impairment, and one-third meet diagnostic criteria for mild cognitive impairment …